The Life Sciences Innovation Fund (LSIF) is an early-stage co-investment fund that supports companies in Life Sciences and Healthcare Technologies sectors related to human health. The fund is aimed at addressing the unique challenges faced by life sciences entrepreneurs moving innovative and capital-intensive investments from a conceptual stage through to commercialization. Through the fund, OCI co-invests with angel and other investors to help de-risk the opportunity, assisting start-ups in becoming investor and customer ready and allowing them to attract follow-on investment.
Our investments drive Canadian business development, economic growth, and scalable impact across the life sciences and healthcare technologies sectors related to human health.
About the Fund
Eligible companies will receive up to $500,000 in early stage risk capital to scale their made-in-Ontario health solution both at home and in global markets. This will further grow the sector and strengthen its competitiveness in key areas such as cancer treatment, regenerative medicine, neuroscience and medical technologies.
Best suited for life sciences and healthcare technologies companies related to human health that:
- Are Ontario or Canadian incorporated for-profit companies headquartered in Ontario
- Currently raising a pre-seed or seed investments (total round sizes ranging from $1 million to $5 million)
- Have raised less than $3 million in third-party capital
Express your interest and see if LSIF is right for your business.
Learn about eligibility, investment criteria, and more.
Contact an Investment Lead
For more information: oci-portforlio(at)oc-innovation(dot)ca
Note: OCI Ready for Market (R4M) Portfolio companies are not eligible for investment via the Life Sciences Innovation Fund (LSIF).
Other OCI Programs
TalentEdge Internship Program (TIP) – NGNP
Digitalization Competence Centre
Collaborate 2 Commercialize
Ontario Vehicle Innovation Network (OVIN)
Life Sciences Innovation Fund